Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.340 | AlteredExpression | disease | BEFREE | The safety of AIT intervention was illustrated by reduced serum BNP levels and cardiac BNP mRNA expression (P < 0.05) after AIT intervention in DCM rats histological analysis and FFA and DAG concentrations revealed that AIT intervention reduced the accumulation of lipid droplets within cardiomyocytes and alleviated cardiac lipotoxicity (P < 0.05). | 31249632 | 2019 | ||||
|
0.340 | AlteredExpression | disease | BEFREE | Myocardial NPPB expression was higher and CORIN expression was lower in the DCMP patients than in the transplant recipients. | 30518715 | 2019 | ||||
|
0.340 | AlteredExpression | disease | BEFREE | In comparison to DCM male mice, DCM female mice also showed differential expression of the natriuretic peptide system with lower corin and higher ANP, BNP and cGMP levels at 13 weeks of age. | 29240788 | 2017 | ||||
|
0.340 | AlteredExpression | disease | BEFREE | Biologically active VEGF that was secreted by NRCM significantly increased BNP mRNA levels in control cardiomyocytes and induced cell-proliferation of cultured cardiac fibroblast (Fibroblast proliferation; NRCM medium/HC-IgG: 1 ± 0.0 vs. NRCM medium/DCM-IgG 100 ng/ml: 5.6 ± 0.9; P < 0.05). | 26248134 | 2015 | ||||
|
0.340 | Biomarker | disease | CTD_human | Dilated cardiomyopathy: an unusual complication of clozapine therapy. | 18628775 | 2008 | ||||
|
0.340 | Therapeutic | disease | CTD_human | Dilated cardiomyopathy: an unusual complication of clozapine therapy. | 18628775 | 2008 | ||||
|
0.340 | Biomarker | disease | CTD_human | Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase. | 16762803 | 2006 | ||||
|
0.340 | Therapeutic | disease | CTD_human | Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase. | 16762803 | 2006 |